Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Brexpiprazole D8 (OPC-34712 D8) is a deuterium-labeled Brexpiprazole. Brexpiprazole is a partial agonist of human 5-HT1A and dopamine receptors (Ki: 0.12 nM and 0.3 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
500 μg | 35 days | $ 658.00 | |
1 mg | 35 days | $ 1,110.00 |
Description | Brexpiprazole D8 (OPC-34712 D8) is a deuterium-labeled Brexpiprazole. Brexpiprazole is a partial agonist of human 5-HT1A and dopamine receptors (Ki: 0.12 nM and 0.3 nM). |
Synonyms | OPC-34712 D8 |
Molecular Weight | 441.62 |
Formula | C25H27N3O2S |
CAS No. | 1427049-21-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Brexpiprazole-d8 1427049-21-5 Others Brexpiprazole d8 Brexpiprazoled8 Brexpiprazole-d-8 OPC-34712 D8 inhibitor inhibit